260 related articles for article (PubMed ID: 28841784)
21. Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma.
Truini A; Coco S; Genova C; Mora M; Dal Bello MG; Vanni I; Alama A; Rijavec E; Barletta G; Biello F; Maggioni C; Grossi F
Microrna; 2016; 5(1):12-18. PubMed ID: 26817512
[TBL] [Abstract][Full Text] [Related]
22. Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals.
Son SW; Lee HY; Moeng S; Kuh HJ; Choi SY; Park JK
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066509
[TBL] [Abstract][Full Text] [Related]
23. Curcumin as an Anticancer Agent in Malignant Mesothelioma: A Review.
Baldi A; De Luca A; Maiorano P; D'Angelo C; Giordano A
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155978
[TBL] [Abstract][Full Text] [Related]
24. New vistas in malignant mesothelioma: MicroRNA architecture and NRF2/MAPK signal transduction.
Gandhi M; Nair S
Life Sci; 2020 Sep; 257():118123. PubMed ID: 32710945
[TBL] [Abstract][Full Text] [Related]
25. Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells.
Valenti D; de Bari L; Manente GA; Rossi L; Mutti L; Moro L; Vacca RA
Biochim Biophys Acta; 2013 Dec; 1832(12):2085-96. PubMed ID: 23911347
[TBL] [Abstract][Full Text] [Related]
26. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function.
Nabekura T; Kamiyama S; Kitagawa S
Biochem Biophys Res Commun; 2005 Feb; 327(3):866-70. PubMed ID: 15649425
[TBL] [Abstract][Full Text] [Related]
27. Phytochemicals for the Management of Melanoma.
Pal HC; Hunt KM; Diamond A; Elmets CA; Afaq F
Mini Rev Med Chem; 2016; 16(12):953-79. PubMed ID: 26864554
[TBL] [Abstract][Full Text] [Related]
28. Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma.
Kao SC; Cheng YY; Williams M; Kirschner MB; Madore J; Lum T; Sarun KH; Linton A; McCaughan B; Klebe S; van Zandwijk N; Scolyer RA; Boyer MJ; Cooper WA; Reid G
J Thorac Oncol; 2017 Sep; 12(9):1421-1433. PubMed ID: 28629895
[TBL] [Abstract][Full Text] [Related]
29. Blockage of epithelial to mesenchymal transition and upregulation of let 7b are critically involved in ursolic acid induced apoptosis in malignant mesothelioma cell.
Sohn EJ; Won G; Lee J; Yoon SW; Lee I; Kim HJ; Kim SH
Int J Biol Sci; 2016; 12(11):1279-1288. PubMed ID: 28090191
[TBL] [Abstract][Full Text] [Related]
30. Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma.
Biersack B
Noncoding RNA Res; 2018 Dec; 3(4):213-225. PubMed ID: 30809600
[TBL] [Abstract][Full Text] [Related]
31. Relations between approved platinum drugs and non-coding RNAs in mesothelioma.
Biersack B
Noncoding RNA Res; 2018 Dec; 3(4):161-173. PubMed ID: 30809599
[TBL] [Abstract][Full Text] [Related]
32. Co-administration of curcumin with other phytochemicals improves anticancer activity by regulating multiple molecular targets.
Ghobadi N; Asoodeh A
Phytother Res; 2023 Apr; 37(4):1688-1702. PubMed ID: 36883534
[TBL] [Abstract][Full Text] [Related]
33. MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma.
Yamamoto K; Seike M; Takeuchi S; Soeno C; Miyanaga A; Noro R; Minegishi Y; Kubota K; Gemma A
Oncol Rep; 2014 Dec; 32(6):2365-72. PubMed ID: 25231602
[TBL] [Abstract][Full Text] [Related]
34. Emerging importance of dietary phytochemicals in fight against cancer: Role in targeting cancer stem cells.
Singh AK; Sharma N; Ghosh M; Park YH; Jeong DK
Crit Rev Food Sci Nutr; 2017 Nov; 57(16):3449-3463. PubMed ID: 26853447
[TBL] [Abstract][Full Text] [Related]
35. Understanding Lung Carcinogenesis from a Morphostatic Perspective: Prevention and Therapeutic Potential of Phytochemicals for Targeting Cancer Stem Cells.
Heng WS; Kruyt FAE; Cheah SC
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071790
[TBL] [Abstract][Full Text] [Related]
36. Role of phytochemicals in colorectal cancer prevention.
Li YH; Niu YB; Sun Y; Zhang F; Liu CX; Fan L; Mei QB
World J Gastroenterol; 2015 Aug; 21(31):9262-72. PubMed ID: 26309353
[TBL] [Abstract][Full Text] [Related]
37. A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma.
Kao SC; Fulham M; Wong K; Cooper W; Brahmbhatt H; MacDiarmid J; Pattison S; Sagong JO; Huynh Y; Leslie F; Pavlakis N; Clarke S; Boyer M; Reid G; van Zandwijk N
Am J Respir Crit Care Med; 2015 Jun; 191(12):1467-9. PubMed ID: 26075427
[No Abstract] [Full Text] [Related]
38. The mTOR signalling pathway in cancer and the potential mTOR inhibitory activities of natural phytochemicals.
Tan HK; Moad AI; Tan ML
Asian Pac J Cancer Prev; 2014; 15(16):6463-75. PubMed ID: 25169472
[TBL] [Abstract][Full Text] [Related]
39. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
van Zandwijk N; Pavlakis N; Kao SC; Linton A; Boyer MJ; Clarke S; Huynh Y; Chrzanowska A; Fulham MJ; Bailey DL; Cooper WA; Kritharides L; Ridley L; Pattison ST; MacDiarmid J; Brahmbhatt H; Reid G
Lancet Oncol; 2017 Oct; 18(10):1386-1396. PubMed ID: 28870611
[TBL] [Abstract][Full Text] [Related]
40. HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma.
Wang Y; Jiang Z; Yan J; Ying S
Dis Markers; 2019; 2019():4183157. PubMed ID: 30891101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
